These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5063370)

  • 1. Immunosuppressive properties of cyclophosphamide analogues.
    Harrison EF; Fuquay ME
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):957-63. PubMed ID: 5063370
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cellular immune reactions by cyclophosphamide analogues ifosfamide and trofosfamide. I. Mixed lymphocyte reaction.
    Devlin RG; Schwartz NL; Baronowsky PE; Zygmunt WA
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):389-91. PubMed ID: 4273394
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract]   [Full Text] [Related]  

  • 4. [Animal experiments on the anti-inflammatory and immunosuppressive effect of cytostatic agents].
    Müller US; Wirth W; Thöne F; Junge-Hülsing G; Hauss WH
    Arzneimittelforschung; 1973 Apr; 23(4):487-91. PubMed ID: 4268068
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.
    Kovach JS; Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Oncology; 1974; 29(1):34-9. PubMed ID: 4837137
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological action.
    Brock N; Kuhlmann J
    Arzneimittelforschung; 1974 Aug; 24(8):1139-49. PubMed ID: 4371234
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic studies with trophosphamide (Ixoten), a new oxazaphosphorineoxide].
    Brock N
    Med Monatsschr; 1973 Sep; 27(9):390-4. PubMed ID: 4768197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppressive effect of L-asparaginase. Cellular and humoral studies].
    Emmerling P; Finger H
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Nov; 140(5):472-81. PubMed ID: 4249814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppression through alkylating agents: hints on the superiority of 5122 ASTA to cyclophosphamide].
    Botzenhardt U; Lemmel EM
    Verh Dtsch Ges Inn Med; 1975; 81():1191-3. PubMed ID: 1229436
    [No Abstract]   [Full Text] [Related]  

  • 11. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract]   [Full Text] [Related]  

  • 12. Intracerebral mouse protection test for petussis vaccine. II. Immunosuppression with cyclophosphamide.
    Blake HE; Wardlaw AC
    Can J Microbiol; 1969 Dec; 15(12):1355-63. PubMed ID: 5369321
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular and humoral antibody production against sheep erythrocytes in AKR mice. 3. Effect of passive antibody on the development of immunological memory.
    Aasted B; Rubin B; Spärck JV
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(6):771-7. PubMed ID: 4945574
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of N,N-2-dichloroethylaniline ("aniline mustard") on the murine immune system.
    Smith AM; Hughes CL
    J Reticuloendothel Soc; 1974 Jul; 16(1):27-36. PubMed ID: 4153510
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression with thyminalkylamine (Ypenyl Spofa): effect on antibody plaque-forming spleen cells.
    Bohunická E; Koza I; Kuzela S; Krempaský V; Ujházy V
    Neoplasma; 1972; 19(5):499-505. PubMed ID: 4404912
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of cyclophosphamide on the primary humoral immune response. The immunological priming.
    Kool GA
    Adv Exp Med Biol; 1973; 29(0):399-405. PubMed ID: 4795105
    [No Abstract]   [Full Text] [Related]  

  • 17. Recovery of the antibody-forming potential in cyclophosphamide-treated mice, with special reference to the influence of Bordetella pertussis.
    Elekes E; Finger H
    Pathol Microbiol (Basel); 1974; 40(1):1-14. PubMed ID: 4358749
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of homocytotropic antibody formation in the rat. IV. Effects of various immunosuppressive drugs.
    Taniguchi M; Tada T
    J Immunol; 1971 Aug; 107(2):579-85. PubMed ID: 4328012
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y.
    Bohunickå E; Koza I; Ujhåzy V
    Neoplasma; 1974; 21(6):659-63. PubMed ID: 4479976
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard.
    Addison IE; Berenbaum MC
    Br J Cancer; 1971 Mar; 25(1):172-81. PubMed ID: 4932848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.